2.2.0.7 false Business Combinations and Divestitures (Details) (USD $) 0603 - Disclosure - Business Combinations and Divestitures (Details) true false false false 1 USD false false Pure Standard http://www.xbrl.org/2003/instance pure xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 Pure Standard http://www.xbrl.org/2003/instance pure xbrli 0 USDEPS Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 $ false 3 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 Pure Standard http://www.xbrl.org/2003/instance pure xbrli 0 USDEPS Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 $ 3 Business Combinations and Divestitures (Textuals) [Abstract] 1 life_BusinessCombinationsAndDivestituresTextualsAbstract life false na duration Business Combinations and Divestitures. false false false false false true false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false xbrli:stringItemType string Business Combinations and Divestitures. false 4 Percentage of sale of ownership stake in the Applied Biosystems/MDS Analytical Technologies Instruments joint venture 2 life_PercentageOfSaleOfOwnershipStakeInJointVenture life false na duration Percentage of sale of ownership stake in joint venture. false false false false false false false false false false false verboselabel false 1 false true false false 0.5 0.5 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false us-types:percentItemType pure Percentage of sale of ownership stake in joint venture. No authoritative reference available. false 5 Proceeds of sale of equity interest in Applied Biosystems/MDS Analytical Technologies Instruments joint venture 2 us-gaap_ProceedsFromDivestitureOfInterestInJointVenture us-gaap true debit duration No definition available. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 true true false false 428100000 428100000 false false false xbrli:monetaryItemType monetary The cash inflow from the sale of an interest in an investment in an entity in which the reporting entity shares control of the entity with another party or group. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 16 false 6 Gain on divestiture of equity investments 2 us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal us-gaap true credit duration No definition available. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false true false false 37260000 37260000 false false false xbrli:monetaryItemType monetary This item represents the amount of gain or loss arising from the disposal of an equity method investment. No authoritative reference available. false 7 Carrying value of equity investments sold 2 us-gaap_EquityMethodInvestmentSoldCarryingAmount us-gaap true debit duration No definition available. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false true false false 330400000 330400000 false false false xbrli:monetaryItemType monetary This item represents the carrying amount of the entity's equity method investment which has been sold. This item should be used only for purposes of disclosing the calculated gain or loss on disposal of the subject equity method investment and not for reporting the carrying value of equity method investments as presented on the entity's balance sheet. For reporting the carrying value of equity method investments presented on the entity's balance sheet, the EquityMethodInvestments (Equity Method Investments) element should be used. No authoritative reference available. false 8 Carrying value of accounts receivable included in sales 2 life_CarryingValueOfAccountsReceivableIncludedInSalesOfJointVenture life false debit instant Carrying Value Of Accounts Receivable Included In Sales of joint venture. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false true false false 71300000 71300000 false false false 3 false true false false 71300000 71300000 false false false xbrli:monetaryItemType monetary Carrying Value Of Accounts Receivable Included In Sales of joint venture. No authoritative reference available. false 9 Carrying value of net inventory included in sales 2 life_CarryingValueOfNetInventoryIncludedInSalesOfJointVenture life false debit instant Carrying value of net inventory included in sales of joint venture. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false true false false 55100000 55100000 false false false 3 false true false false 55100000 55100000 false false false xbrli:monetaryItemType monetary Carrying value of net inventory included in sales of joint venture. No authoritative reference available. false 10 Carrying value of other current assets included in sales 2 life_CarryingValueOfOtherCurrentAssetsIncludedInSalesOfJointVenture life false debit instant Carrying value of other current assets included in sales of joint venture. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false true false false 17600000 17600000 false false false 3 false true false false 17600000 17600000 false false false xbrli:monetaryItemType monetary Carrying value of other current assets included in sales of joint venture. No authoritative reference available. false 11 Carrying value of long term assets included in sales 2 life_CarryingValueOfLongTermAssetsIncludedInSalesOfJointVenture life false debit instant Carrying value of long term assets included in sales of joint venture. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false true false false 13700000 13700000 false false false 3 false true false false 13700000 13700000 false false false xbrli:monetaryItemType monetary Carrying value of long term assets included in sales of joint venture. No authoritative reference available. false 12 Carrying value of accounts payable included in sales 2 life_CarryingValueOfAccountsPayableIncludedInSalesOfJointVenture life false credit instant Carrying value of accounts payable included in sales of joint venture. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false true false false 9800000 9800000 false false false 3 false true false false 9800000 9800000 false false false xbrli:monetaryItemType monetary Carrying value of accounts payable included in sales of joint venture. No authoritative reference available. false 13 Carrying value of other current liabilities included in sales 2 life_CarryingValueOfOtherCurrentLiabilitiesIncludedInSalesOfJointVenture life false credit instant Carrying value of other current liabilities included in sales of joint venture. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false true false false 80800000 80800000 false false false 3 false true false false 80800000 80800000 false false false xbrli:monetaryItemType monetary Carrying value of other current liabilities included in sales of joint venture. No authoritative reference available. false 14 Carrying value of long term liabilities included in sales 2 life_CarryingValueOfLongTermLiabilitiesIncludedInSalesOfJointVenture life false credit instant Carrying value of long term liabilities included in sales of joint venture. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 false true false false 6700000 6700000 false false false 3 false true false false 6700000 6700000 false false false xbrli:monetaryItemType monetary Carrying value of long term liabilities included in sales of joint venture. No authoritative reference available. false 16 Cost for continued integration of recent and pending acquisitions and divestitures into operations 2 us-gaap_BusinessCombinationAcquisitionRelatedCosts us-gaap true debit duration No definition available. false false false false false false false false false false false verboselabel false 1 false false false false 0 0 false false false 2 true true false false 23446000 23446000 false false false 3 true true false false 48712000 48712000 false false false xbrli:monetaryItemType monetary This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 59 false 3 13 false NoRounding UnKnown UnKnown false true